Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Quartuccio L, Bortoluzzi A, Scirè CA, Marangoni A, Del Frate G, Treppo E, Castelnovo L, Saccardo F, Zani R, Candela M, Fraticelli P, Mazzaro C, Renoldi P, Scaini P, Filippini DA, Visentini M, Scarpato S, Giuggioli D, Mascia MT, Sebastiani M, Zignego AL, Lauletta G, Fiorilli M, Casato M, Ferri C, Pietrogrande M, Pioltelli PE, De Vita S, Monti G, Galli M. Quartuccio L, et al. Among authors: mazzaro c. Clin Rheumatol. 2023 Feb;42(2):359-370. doi: 10.1007/s10067-022-06391-w. Epub 2022 Sep 28. Clin Rheumatol. 2023. PMID: 36169798 Free PMC article. Review.
Hepatitis C virus in mixed cryoglobulinemia and B cell lymphoma.
Ferri C, La Civita L, Longombardo G, Lombardini F, Pasero G, Zignego AL, Monti M, Mazzaro C, Greco F, Mazzoni A. Ferri C, et al. Among authors: mazzaro c. Clin Exp Rheumatol. 1994 Jan-Feb;12(1):89-90. Clin Exp Rheumatol. 1994. PMID: 8162649 No abstract available.
Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, Michelutti A, Baccarani M, Fanin R, Ferraccioli G. Zaja F, et al. Among authors: mazzaro c. Blood. 2003 May 15;101(10):3827-34. doi: 10.1182/blood-2002-09-2856. Epub 2003 Jan 30. Blood. 2003. PMID: 12560225 Free article. Clinical Trial.
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias.
Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, Cavallero G, De Vita S, Ferri C, Mazzaro C, Migliaresi S, Ossi E, Pietrogrande M, Gabrielli A, Galli M, Invernizzi F. Monti G, et al. Among authors: mazzaro c. Arch Intern Med. 2005 Jan 10;165(1):101-5. doi: 10.1001/archinte.165.1.101. Arch Intern Med. 2005. PMID: 15642884
Role of the HLA class II: HCV-related disorders.
De Re V, Caggiari L, Simula MP, De Vita S, Mazzaro C, Lenzi M, Massimo GM, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Tirelli U, Cannizzaro R, Dolcetti R. De Re V, et al. Among authors: mazzaro c. Ann N Y Acad Sci. 2007 Jun;1107:308-18. doi: 10.1196/annals.1381.033. Ann N Y Acad Sci. 2007. PMID: 17804559
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus.
De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R. De Re V, et al. Among authors: mazzaro c. Dig Liver Dis. 2007 Sep;39 Suppl 1:S65-71. doi: 10.1016/s1590-8658(07)80014-4. Dig Liver Dis. 2007. PMID: 17936227
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes].
Fabris M, Quartuccio L, De Re V, Pozzato G, Mazzaro C, Tavoni A, Ferri C, Salvin S, Lerussi A, Fabro C, Bombardieri S, De Vita S. Fabris M, et al. Among authors: mazzaro c. Reumatismo. 2008 Jan-Mar;60(1):28-34. doi: 10.4081/reumatismo.2008.28. Reumatismo. 2008. PMID: 18810851 Free article. Italian.
96 results